Notably, Kaplan-Meier survival curve analyses showed that higher stromal expression of FN was associated with poorer overall survival (OS) and progression-free survival (PFS) in patients with ESCC (OS, P = 0.002; PFS, P < 0.001). This evidence concerns the gene FN1 and esophageal squamous cell carcinoma.